KDOQI (Kidney Disease Outcomes Quality Initiative)


NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of K/DOQ | Pediatric Bone |

KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children With Chronic Kidney Disease


Tables

Table 1.

Signs and Symptoms of Bone Disease in Children with CKD
Table 2.

Frequency of Measurement of PTH, Calcium, Phosphorus, Total CO2, and Alkaline Phosphatase by Stage of CKD

Table 3. Target Range of Serum PTH by Stage of CKD
Table 4. Histological Features of High-Turnover Renal Osteodystrophy
Table 5. Histological Features of Low-Turnover Renal Osteodystrophy
Table 6.

Representative Normal Values for Serum Phosphorus, Total Calcium, Blood Ionized Calcium, and Alkaline Phosphatase Concentrations

Table 7.

Dietary Reference Intakes of Phosphorus in Children

Table 8. Steps to Calculate the Initial Binder Prescription
Table 9. Phosphorus-Binding Compounds
Table 10. Recommendations for Calcium Intake
Table 11.

Calcium Content of Common Calcium-Based Binders

Table 12. Low-Phosphorus, High-Calcium Foods
Table 13. Partial List of Calcium-Containing Supplements
Table 14. Determining Calcium Requirements in Adults Aged 19-30 Years
Table 15. Recommended Supplementation for Vitamin D Deficiency/Insufficiency in Patients with CKD Stages 3-4
Table 16.

Serum Levels of PTH, Calcium, and Phosphate Required for Initiation of Oral Vitamin D Sterol Therapy, and Recommended Initial Doses in Patients with CKD Stages 2-4

Table 17.

Initial Calcitriol Dosing Recommendations for Children on Maintenance Dialysis

Table 18. Aluminum-Related Disorders: Features, Causes, and Considerations for Therapy
Table 19.

Frequency for Measurement of Serum Levels of Total CO2

Table 20. Frequency of Measurement of Calcium, Phosphorus, PTH, and Total CO2 after Kidney Transplantation